ISG15 and non-small cell lung carcinoma: Importantly, high combined expression of SIRT1 and ISG15 (SIRT1hi/ISG15hi (log-rank P < 0.001)) was positively correlated with poor prognosis in NSCLC patients (Fig. 7e).